SCHEMBL8076708

SCHEMBL8076708

COc1ccc(CC(C=O)Cc2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.60
CA2 P00918 1/20 0.55
ALDH1A1 P00352 3/20 0.51
PPARG P37231 1/20 0.51
PPARD Q03181 1/20 0.51
PPARA Q07869 1/20 0.51
ALOX15 P16050 2/20 0.51
ALOX12 P18054 2/20 0.51
KDM4E B2RXH2 2/20 0.49
ATM Q13315 2/20 0.49
POLB P06746 2/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
STAT3 P40763 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14221287 0.89 STAT3 (0.55) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL4247499 0.86 LDHA (0.60) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL5792794 0.84 LDHA (0.58) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL3388464 0.83 LDHA (0.57) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL4624772 0.83 LDHA (0.57) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL2575301 0.81 LDHA (0.55) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL2568835 0.81 LDHA (0.55) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL31666050 0.81 LDHA (0.55) LDHACA2ALDH1A1PPARGPPARD
SCHEMBL30008939 0.81 MTNR1A (0.54) LDHACA2ALDH1A1ALOX15ALOX12
SCHEMBL28888984 0.81 MTNR1A (0.54) LDHACA2ALDH1A1ALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127426-A ANTIALLERGIC AND -INFLAMMATORY AGENTS E.G., TREATING PSORIASIS, BLOCKED ON THE C-10 BY A NONPHENOLIC ARYLACYL OR A PHENYLALKYLIDENE GROUP; LIPOXYGENASE INHIBITORS; ANTIPROLIFERATIVE AGENTS; LOW DOSAGE; SIDE EFFECT REDUCTION TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2000-10-03 US disclosed
EP-0664780-B1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMA (IL) 1999-12-08 EP disclosed
US-5952390-A ANTIINFLAMMATORY AGENTS; TREATMENT FOR PSORIASIS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1999-09-14 US disclosed
US-5844004-A 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1998-12-01 US disclosed
US-5661187-A ADMINISTERING TO TREAT AN ALLERGIC OR INFLAMMATORY CONDITION; SIDE EFFECT REDUCTION TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1997-08-26 US disclosed
EP-0664780-A1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1995-08-02 EP disclosed
US-5426197-A Antiinflammatory, antiallergy or antitumor agents TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1995-06-20 US disclosed
WO-1995003266-A1 10-SUBSTITUTED 1,8-DIHYDROXY-9(10H) ANTHRACENONE PHARMACEUTICALS TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 1995-02-02 WO disclosed